Belgium· BE-AMP-SAM172067-00
Mivacron 20 mg/10 ml
A mivacurium chloride product containing mivacurium chloride, registered in Belgium by Aspen Pharma Trading. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Mivacurium chloride is registered in 8 of 19 countries.
Countries holding a registration under ATC M03AC10 (mivacurium chloride), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Mivacurium chloride · ATC M03AC10
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Mivacurium Chloride
- Manufacturer
- Aspen Pharma Trading
- Country
- Belgium (BE)
- ATC code
- M03AC10
- ATC class
- Mivacurium chloride
- Defined daily dose
- 14 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0745208
- be_apb1114404
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
76 interactions on record for mivacurium chloride.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mivacurium chloride · interactions on record
76 records
- 12 severe
- 60 moderate
- 4 minor
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mivacurium chloride in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMIVACRONAspen Pharma Trading Limited, Dublin
- NorwayMivacronAspen Pharma Trading Limited
- GermanyMivacronAspen Pharma Trading Limited
- FinlandMivacronAspen Pharma Trading Limited
- IrelandMivacron 2 mg/ml Solution for InjectionAspen Pharma Trading Limited
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Czechia · Mivacron
- Germany · Mivacron
- France · Mivacron
- United Kingdom (Northern Ireland) · Mivacron
- Hungary · Mivacron
- Ireland · Mivacron
- Italy · Mivacron
- Norway · Mivacron
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be49090c-f0eb-425f-aef1-daf2f1598c3f GET /v1/drugs/be49090c-f0eb-425f-aef1-daf2f1598c3f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "REVOKED",
"name_en": "Mivacron 20 mg/10 ml",
"name_fr": "Mivacron 20 mg/10 ml",
"name_nl": "Mivacron 20 mg/10 ml",
"amp_code": "SAM172067-00",
"strengths": [
"2.0000",
"2.0000"
],
"pack_count": 1,
"substances": [
"Mivacurium Chloride",
"Mivacurium"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Mivacurium Chloride",
"authorisation_numbers": [
"BE172067"
]
}See everything about mivacurium chloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.